Advertisement
Singapore markets closed
  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     
  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • Bitcoin USD

    60,921.82
    -2,062.75 (-3.27%)
     
  • CMC Crypto 200

    1,261.13
    -96.88 (-7.13%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • Dow

    39,512.84
    +125.08 (+0.32%)
     
  • Nasdaq

    16,340.87
    -5.40 (-0.03%)
     
  • Gold

    2,366.90
    +26.60 (+1.14%)
     
  • Crude Oil

    78.20
    -1.06 (-1.34%)
     
  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     
  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     
  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     
  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

RXi Pharmaceuticals (RXII) Jumps: Stock Moves 11.4% Higher

RXi Pharmaceuticals Corporation (RXII) was a big mover last session with its shares rising over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock has gained nearly 34% in the past one-month time frame.

This biotechnology company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

RXi Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the Med-Drugs industry may consider better-ranked stocks like Mallinckrodt plc (MNK), Lannett Company, Inc. (LCI) and Endo International plc (ENDP). All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



RXI PHARMACEUTICALS CORP (RXII): Free Stock Analysis Report

MALLINCKRODT PUBLIC LTD CO (MNK): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report

ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report


Zacks Investment Research